|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn246733059 |
003 |
OCoLC |
005 |
20231117015118.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
080908s2008 enkabf ob 001 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e pn
|c OPELS
|d OPELS
|d OCLCQ
|d FUH
|d BTCTA
|d OCLCQ
|d COO
|d OCLCQ
|d UKMGB
|d OCLCF
|d OCLCO
|d OCLCA
|d CHVBK
|d OCLCO
|d NLGGC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d D6H
|d OCLCO
|d AUD
|d OCLCO
|d AU@
|d OCLCO
|d OCLCA
|d OCLCQ
|d LEAUB
|d OCLCO
|d U3G
|d OCLCA
|d S2H
|d OCLCO
|d EUN
|d OCLCO
|d OCLCQ
|
016 |
7 |
|
|a 014690992
|2 Uk
|
019 |
|
|
|a 316567007
|a 370376591
|a 1112875593
|
020 |
|
|
|a 9780123694089
|
020 |
|
|
|a 0123694086
|
035 |
|
|
|a (OCoLC)246733059
|z (OCoLC)316567007
|z (OCoLC)370376591
|z (OCoLC)1112875593
|
050 |
|
4 |
|a RA643
|b .V33 2009
|
060 |
|
4 |
|a 2009 C-124
|
060 |
|
4 |
|a QW 805
|b V11642 2009
|
070 |
|
|
|a RA643
|b .V33 2009
|
082 |
0 |
4 |
|a 614.47
|2 22
|
245 |
0 |
0 |
|a Vaccines for biodefense and emerging and neglected diseases /
|c edited by Alan D.T. Barrett, Lawrence R. Stanberry.
|
250 |
|
|
|a 1st ed.
|
260 |
|
|
|a Amsterdam ;
|a Boston :
|b Academic,
|c 2009.
|
300 |
|
|
|a 1 online resource (xxvii, 1478 pages, 12 unnumbered pages of plates) :
|b illustrations (some color), maps (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a The last 20 years has seen a rapid increase in infectious diseases, particularly those that are termed "emerging diseases" such as SARS, "neglected diseases" such as malaria and those that are deemed biothreats such as anthrax. It is well-recognized that the most effective modality for preventing infectious diseases is vaccination. This book provides researchers with a better understanding of what is currently known about these diseases, including whether there is a vaccine available or under development. It also informs them of what they need to do if they are currently working on developing a vaccine. * Provides a comprehensive treatise of the agents that are responsible for emerging and neglected diseases and those that can be used as biothreats * Includes the processes such as the vaccine development pathway, vaccine manufacturing and regulatory issues that are critical to the generation of these vaccines to the marketplace * Each chapter will include a map of the world showing where that particular disease is naturally found
|
505 |
0 |
|
|a Agents of Emerging Infectious Diseases; Bacterial biothreats agents; Viral Biothreat agents; Vaccine Development Pathway; Immunology of Vaccines; Molecular Approches to Bacterial Vaccines; Viral Vectors; DNA Vaccines; Vaccine Adjuvants; Preclinical Vaccine Development; Vaccine Manufacturing; Clinical Trials of Vaccines; Pre-IND/IND Process; Regulatory Issues-USA; Special Issues around Veterinary Vaccines; Vaccines Misinformation; Vaccine for Military Application; Dengue; Filoviruses; Alphaviral Encephalitides; Foot & Mouth; Hantaviruses; -- Hepatitis; HIV; Human papillomavirus; Influenza; Japanese encephalitis; Junin & other Arenaviruses; Measles; Nipah and Hendra; O'Nyong, N'yong, and Chikungunya Viruses; Rabies; Ross River Virus; Rotavirus; SARS; Smallpox; Tick Borne Encephalitis; West Nile Virus; Yellow Fever; Anthrax; Brucellosis; Burkholderia mallei and Burkholderia pseudomallei; Chlamydia; Cholea; Botulinum; Erlichia; Extraintestinal pathogenic E. coli; Gonnorhea; Helicobactor pylori; Intestinal pathogenic E. coli; Lyme Disease; Niesseria meningitidis; Plague; Ricin-a toxin; Rickettsia; Salmonella; Shigella; Syphilis; Tuberculosis; Tularemia; African trypanosomiasis; Leishmaniasis; Leptospirosis; Malaria; Hookworm; Onchocerciasis; Schistosomiasis; American Trypanosomiasis.
|
588 |
0 |
|
|a Print version record.
|
650 |
|
0 |
|a Vaccines.
|
650 |
|
0 |
|a Communicable diseases
|x Prevention.
|
650 |
|
0 |
|a Communicable diseases
|x Epidemiology.
|
650 |
1 |
2 |
|a Communicable Disease Control
|0 (DNLM)D003140
|
650 |
1 |
2 |
|a Communicable Diseases, Emerging
|x prevention & control
|0 (DNLM)D021821Q000517
|
650 |
1 |
2 |
|a Vaccines
|0 (DNLM)D014612
|
650 |
2 |
2 |
|a Bioterrorism
|x prevention & control
|0 (DNLM)D023482Q000517
|
650 |
2 |
2 |
|a Communicable Diseases
|x epidemiology
|0 (DNLM)D003141Q000453
|
650 |
|
6 |
|a Vaccins.
|0 (CaQQLa)201-0018490
|
650 |
|
6 |
|a Maladies infectieuses
|x Pr�evention.
|0 (CaQQLa)201-0012311
|
650 |
|
6 |
|a Maladies infectieuses
|0 (CaQQLa)201-0001354
|x �Epid�emiologie.
|0 (CaQQLa)201-0395682
|
650 |
|
7 |
|a Communicable diseases
|x Epidemiology.
|2 fast
|0 (OCoLC)fst00869891
|
650 |
|
7 |
|a Communicable diseases
|x Prevention.
|2 fast
|0 (OCoLC)fst00869910
|
650 |
|
7 |
|a Vaccines.
|2 fast
|0 (OCoLC)fst01163573
|
700 |
1 |
|
|a Barrett, A. D. T.
|q (Alan D. T.)
|
700 |
1 |
|
|a Stanberry, Lawrence R.
|
776 |
0 |
8 |
|i Print version:
|t Vaccines for biodefense and emerging and neglected diseases.
|b 1st ed.
|d Amsterdam ; Boston : Academic, 2009
|z 9780123694089
|z 0123694086
|w (OCoLC)243820233
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123694089
|z Texto completo
|